The current valuation score of IGC Pharma Inc is 6.24, ranking 344 out of 387 in the Biotechnology & Medical Research industry. Its current P/E ratio is 43.12, which is 9.21% below the recent high of 47.10 and 117.44% above the recent low of -7.52.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.